000 | 01875 a2200481 4500 | ||
---|---|---|---|
005 | 20250513150308.0 | ||
264 | 0 | _c19980908 | |
008 | 199809s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.95.16.9208 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStreeper, R S | |
245 | 0 | 0 |
_aHepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cAug 1998 |
||
300 |
_a9208-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aChloramphenicol O-Acetyltransferase _xgenetics |
650 | 0 | 4 | _aDNA Primers |
650 | 0 | 4 | _aDNA-Binding Proteins |
650 | 0 | 4 |
_aGlucose-6-Phosphatase _xgenetics |
650 | 0 | 4 | _aHepatocyte Nuclear Factor 1 |
650 | 0 | 4 | _aHepatocyte Nuclear Factor 1-alpha |
650 | 0 | 4 | _aHepatocyte Nuclear Factor 1-beta |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 | _aNuclear Proteins |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aEaton, E M | |
700 | 1 | _aEbert, D H | |
700 | 1 | _aChapman, S C | |
700 | 1 | _aSvitek, C A | |
700 | 1 | _aO'Brien, R M | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 95 _gno. 16 _gp. 9208-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.95.16.9208 _zAvailable from publisher's website |
999 |
_c9654739 _d9654739 |